Sygnature Discovery, a Nottingham, UK-based integrated drug discovery services provider, has appointed Dr Gerry Thomas as Director of Business Development.
Thomas has spent more than 20 years in drug discovery and development at Boots Pharmaceuticals, BASF/Knoll, OSI Pharmaceuticals, Prosidion and Shire Pharmaceuticals.
Board Director Dr Paul Clewlow says Thomas will be instrumental in promoting Sygnature's integrated drug discovery capabilities and expertise across Europe and North America.
